As was found by immunocytochemical analysis of breast cancer cell lines (Figure 1F), TMEM26 specific-immunoreactivity was found in the cytoplasm, but not in the nucleus of the tumor cells (Figure 6). Here, TMEM26 is linked to neoplasm.